FDA OKs Nivolumab in Metastatic Colorectal Cancer FDA OKs Nivolumab in Metastatic Colorectal Cancer

The FDA has given accelerated approval to nivolumab for the treatment of microsatellite instability-high or mismatch repair deficient metastatic colorectal cancer.FDA Approvals
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Alert Source Type: news